| JXSB2400107 | AMG 509 | AMG-509 | Injection | Biological Products(1) | Supplementary Application | 2024-07-31 | | Amgen Inc | | | view |
| JXSB2400004 | AMG 509 | AMG-509 | Injection | Biological Products(1) | Supplementary Application | 2024-01-17 | | Amgen Inc | | | view |
| JXHB2400004 | BI685509片 | Avenciguat | Tablet | Chemical Drugs(1) | Supplementary Application | 2024-01-04 | | Boehringer Ingelheim International GmbH | | | view |
| JXHB2400006 | BI685509片 | Avenciguat | Tablet | Chemical Drugs(1) | Supplementary Application | 2024-01-04 | | Boehringer Ingelheim International GmbH | | | view |
| JXHB2400005 | BI685509片 | Avenciguat | Tablet | Chemical Drugs(1) | Supplementary Application | 2024-01-04 | | Boehringer Ingelheim International GmbH | | | view |
| CXHL2301244 | HS-10509片 | HS-10509 | Tablet | Chemical Drugs(1) | New Drug Application | 2023-11-08 | | | | | view |
| CXHL2301243 | HS-10509片 | HS-10509 | Tablet | Chemical Drugs(1) | New Drug Application | 2023-11-08 | | | | | view |
| CXHL2301242 | HS-10509片 | HS-10509 | Tablet | Chemical Drugs(1) | New Drug Application | 2023-11-08 | | | | | view |
| JXSL2300177 | AMG 509 | AMG-509 | Injection | Biological Products(1) | Import Drug Application | 2023-10-11 | | | | | view |
| JXHL2300193 | BI685509片 | Avenciguat | Tablet | Chemical Drugs(1) | Import Drug Application | 2023-08-22 | | | | | view |
| JXHL2300194 | BI685509片 | Avenciguat | Tablet | Chemical Drugs(1) | Import Drug Application | 2023-08-22 | | | | | view |
| JXHL2300195 | BI685509片 | Avenciguat | Tablet | Chemical Drugs(1) | Import Drug Application | 2023-08-22 | | | | | view |
| JXSL2300063 | AMG 509 | AMG-509 | Injection | Biological Products(1) | Import Drug Application | 2023-03-31 | | | | | view |
| JXHB2200167 | BI685509片 | Avenciguat | Tablet | Chemical Drugs(1) | Supplementary Application | 2022-11-03 | | Boehringer Ingelheim International GmbH | | | view |
| JXHB2200169 | BI685509片 | Avenciguat | Tablet | Chemical Drugs(1) | Supplementary Application | 2022-11-03 | | Boehringer Ingelheim International GmbH | | | view |
| JXHB2200168 | BI685509片 | Avenciguat | Tablet | Chemical Drugs(1) | Supplementary Application | 2022-11-03 | | Boehringer Ingelheim International GmbH | | | view |
| JXHL2200205 | BI685509片 | Avenciguat | Tablet | Chemical Drugs(1) | Import Drug Application | 2022-07-20 | | | | | view |
| JXHL2200206 | BI685509片 | Avenciguat | Tablet | Chemical Drugs(1) | Import Drug Application | 2022-07-20 | | | | | view |
| JXHL2200207 | BI685509片 | Avenciguat | Tablet | Chemical Drugs(1) | Import Drug Application | 2022-07-20 | | | | | view |
| JXHB2200081 | GH509 | GH509 | Active ingredient | Chemical Drugs(1) | Supplementary Application | 2022-06-23 | | | | | view |
